Konami T
Hinyokika Kiyo. 1987 Jan;33(1):1-14.
To establish a useful combination chemotherapy of advanced renal cell carcinoma, I determined the optimal design of therapeutic schedules with an in vitro experimental model. At first, I determined the chemosensitivity of the NC-65 cell line established from human renal cell carcinoma. The method used is an original growth inhibition test which traces the cell growth in the same area by photography. This method can be completed in a short term and cell growth inhibition rate evaluated sequentially and precisely as well. Among 8 tested drugs, vincristine (VCR), adriamycin (ADM) and carboquone (CQ) were the most effective drugs. The effect of these three drugs on cell cycle traverse was estimated by flow cytometry. With all of these three drugs, at a concentration which inhibits cell growth less than 50%, an accumulation of cells in the S and G2-M phases was observed 12 hours after the exposure to the drugs. Although 24 hours later, the histogram showed the increase in cells of a G1 phase and decrease in G2-M cells, followed by the cell progression partially synchronized. The tendency was the most characteristic in VCR although it was not so significant in CQ. Effectiveness of the simultaneous or sequential combination of two-drugs was compared to the calculated expected effect using the t-test. At a low concentration which inhibits cell growth 32% (IC 32), most of the combination groups showed a weak effect. Sequential treatment at 12-hour intervals such as with VCR-ADM, CQ-VCR, CQ-ADM, were considered more effective than that of a 24-hour interval. In the medium concentration which inhibits cell growth 50% (IC 50), simultaneous administration of ADM and CQ showed a relatively high inhibition rate. Sequential treatment of CQ followed by VCR was the most cytotoxic. Comparison of sequential administration schedules, administration at 12-hour intervals showed a higher inhibition rate than that of a 24-hour interval, in the combination of VCR-ADM, CQ-ADM.
为建立一种有效的晚期肾细胞癌联合化疗方案,我利用体外实验模型确定了治疗方案的最佳设计。首先,我测定了从人肾细胞癌建立的NC - 65细胞系的化疗敏感性。所采用的方法是一种原始的生长抑制试验,通过拍照追踪同一区域的细胞生长。该方法可在短期内完成,并且能依次精确评估细胞生长抑制率。在8种受试药物中,长春新碱(VCR)、阿霉素(ADM)和卡波醌(CQ)是最有效的药物。通过流式细胞术评估这三种药物对细胞周期进程的影响。使用这三种药物中的任何一种,在抑制细胞生长小于50%的浓度下,给药12小时后观察到细胞在S期和G2 - M期积累。尽管24小时后,直方图显示G1期细胞增加,G2 - M期细胞减少,随后细胞进程部分同步。这种趋势在VCR中最为明显,尽管在CQ中不太显著。使用t检验将两种药物同时或序贯联合的有效性与计算出的预期效果进行比较。在抑制细胞生长32%(IC 32)的低浓度下,大多数联合组显示出较弱的效果。以12小时间隔进行序贯治疗,如VCR - ADM、CQ - VCR、CQ - ADM,被认为比24小时间隔更有效。在抑制细胞生长50%(IC 50)的中等浓度下,ADM和CQ同时给药显示出相对较高的抑制率。CQ后接VCR的序贯治疗细胞毒性最大。比较序贯给药方案,在VCR - ADM、CQ - ADM联合中,12小时间隔给药的抑制率高于24小时间隔给药。